Skip to main content
Georgia Public Broadcasting Logo
  • TV

    Featured Specials and Programs

    • All Creatures Great and Small
    • Miss Scarlet & The Duke
    • Antiques Roadshow
    • PBS Newshour
    • Finding Your Roots
    • The U.S. and the Holocaust
    All Programs

    GPB Originals

    • Georgia Outdoors
    • View Finders
    • A Fork in the Road
    • The Steeple
    • Your Fantastic Mind
    • Football Fridays in Georgia
    GPB Originals

    Browse by Genre

    • Arts & Music
    • Culture
    • Drama
    • Food
    • History
    • News & Public Affairs
    • TV Schedule
    • GPB Programs
    • PBS Passport
    • TV Highlights this Week
    • PBS KIDS
    • Ways to Watch
    • Newsletters
    • Contact GPB
  • Radio

    Featured Programs

    • Political Rewind
    • The Daily
    • Morning Edition
    • All Things Considered
    • Serendipity
    • John Lemley's City Cafe
    • Fresh Air
    • Here and Now
    • Code Switch/Life Kit
    • Wait Wait... Don't Tell Me!
    All Programs

    Podcasts

    • GA Today
    • Salvation South
    • Battleground: Ballot Box
    • Football Fridays in Georgia
    • Classroom Conversations
    • Radio Schedule
    • GPB Classical
    • Radio Programs
    • Podcasts
    • GPB News
    • Find Your Station
    • Contact GPB
    • Newsletters
  • News

    Featured Programs & Series

    • Political Rewind
    • Lawmakers
    • Lawmakers: Beyond the Dome
    • 1A
    • Battleground: Ballot Box
    • GA Today Podcast
    • Storycorps
    • Powering Georgia
    • Food Access

    More GPB News

    • Politics
    • Georgia News
    • Justice
    • Arts & Life
    • Health
    All GPB News
    • Radio Schedule
    • Radio Stations
    • GPB Apps
    • Contact GPB News
    • Follow Us on Apple News
    • Newsletters
  • Education

    Browse by Subject

    • CTAE
    • Computer Science
    • English Language Arts
    • Mathematics
    • Physical Health and Wellness
    • Professional Learning
    • STEAM
    • Science
    • Social Studies
    • The Arts
    • World Languages

    Browse by Grade

    • Preschool-PreK
    • K-2
    • 3-5
    • 6-8
    • 9-12

    Featured

    • Classroom Conversations Podcast
    • Georgia Studies Collection
    • Econ Express
    • VR in the Classroom
    • Lights, Camera, Budget!
    • Georgia Home Classroom
    • Chemistry Matters
    • Physics in Motion
    • Virtual Field Trips
    • Writers Contest
    • PBS LearningMedia
    • PBS KIDS
  • Sports

    GHSA Sports

    • Football
    • Basketball
    • Cheerleading
    • On Demand
    • GPB Sports Blog
    All Sports

    High School Football

    • Scores & Schedule
    • On Demand
    • Teams
    • Rankings
    • Brackets
    • Champions
    • Buckle Up Georgia
    Football Home
    • GPB Sports App
    • GPB Sports Blog
    • GPB Sports OnDemand
  • Events

    Browse by Type

    • Community
    • Donor
    • Kids & Family
    • Screenings
    All Events

    Browse by Category

    • Education
    • News
    • Sports
    • Television

    Sign up to receive GPB Event announcements via Email.

    Sign up

    • on Twitter
    • on Facebook
    • on Instagram
  • Kids & Family

    For Kids

    • Video
    • Games

    For Parents & Caregivers

    • Kids & Family Blog
    • Kids & Family Events
    • GPB KIDS - Ways to Watch
  • Support Us

    Support GPB

    • Ways to Give
    • Planned Giving
    • Sustainers
    • GPB Passport
    • Leadership Giving
    • Corporate Sponsorship
    • Vehicle Donations
    • GPB Next
    • Matching Gifts
  • Search
GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Listen Live Listen Live Watch Live Watch Live
GPB News

GPB Newsletter CTA

Sign Up For Our Newsletter

News Topics

  • Georgia
  • National
  • Election
  • Lawmakers
  • Battleground: Ballot Box

Don't Miss

Don't Miss:

  • Listen: The NEW Peach Jam podcast
  • TV Highlights This Week
  • GA Today daily podcast

News Articles: pfizer

The first vaccine to protect infants from respiratory syncytial virus, or RSV, moved a step toward approval by the Food and Drug Administration with positive votes Thursday from a panel of experts.

Tagged as: 

  • Health

FDA advisers support approval of RSV vaccine to protect infants

At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.

May 18, 2023
|
By:
  • Scott Hensley and
  • Rob Stein
Vials of the reformulated Pfizer-BioNTech COVID-19 booster move through production at a plant in Kalamazoo, Mich.

Tagged as: 

  • Health

CDC recommends new booster shots to fight omicron

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.

September 01, 2022
|
By:
  • Jane Greenhalgh and
  • Rob Stein
Vials of the newly reformulated COVID-19 vaccine booster are being readied by Pfizer for distribution now that the Food and Drug Administration has authorized the shots for people 12 and older.

Tagged as: 

  • Health

FDA authorizes first revamp of COVID vaccines to target omicron

The new shots from Moderna and Pfizer-BioNTech target both the original strain of the coronavirus and the omicron BA.4/BA.5 subvariants that most people are catching now.

August 31, 2022
|
By:
  • Scott Hensley and
  • Rob Stein
A single-use syringe awaits to be filled with the Moderna COVID-19 vaccine. Moderna has sued rival drugmakers for patent infringement.

Tagged as: 

  • Health

Moderna sues Pfizer over COVID-19 vaccine patents

The vaccine maker alleges that its rivals Pfizer and BioNTech used some patented features of its mRNA technology to develop their COVID vaccines.

August 26, 2022
|
By:
  • Carmel Wroth and
  • Joe Palca
The new booster shot would be an update to Pfizer's current version of the shot, which was designed for the original strain of the coronavirus.

Tagged as: 

  • Health

Pfizer asks FDA to greenlight new omicron booster shots, which could arrive this fall

Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.

August 22, 2022
|
By:
  • Pien Huang and
  • Will Stone
A child receives the Pfizer BioNTech COVID-19 vaccine at the Fairfax County Government Center in Annandale, Va.,  in November 2021. A committee of advisers to the Food and Drug Administration recommended Wednesday that the agency expand authorization of COVID-19 vaccines to children as young as 6-months-old.

Tagged as: 

  • Health

Advisers to the FDA back COVID vaccines for the youngest children

A committee of experts voted unanimously to recommend that the Food and Drug Administration authorize COVID-19 vaccines from Moderna and Pfizer-BioNTech for children as young as 6-months-old.

June 15, 2022
|
By:
  • Scott Hensley
Finn Washburn, 9, receives an injection of the Pfizer-BioNTech COVID-19 vaccine in San Jose, Calif., in November. Now the pharmaceutical companies are seeking authorization to give kids a booster dose of the vaccine.

Tagged as: 

  • Health

Pfizer asks FDA to authorize booster shots for kids ages 5 through 11

Data show that a third dose can help boost kids' immunity. Some experts are skeptical that another shot is needed for younger kids.

April 26, 2022
|
By:
  • Rob Stein
A health care worker prepares the current COVID vaccine booster shots from Moderna in February. The company says a bivalent vaccine that combines the original strain with the omicron strain is the lead candidate for a fall vaccination campaign.

Tagged as: 

  • Health

Moderna says its new 'bivalent' vaccine shows promise against COVID variants

The company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.

April 19, 2022
|
By:
  • Rob Stein
A staff member poses with a vial of Pfizer-BioNTech COVID-19 vaccine at a vaccination health center.

Tagged as: 

  • Health

Pfizer-BioNTech will seek authorization for second COVID booster for older adults

Pfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.

March 15, 2022
|
By:
  • Scott Hensley
A medical worker prepares the Pfizer-BioNTech Covid-19 vaccine booster in Hartford, Connecticut, in January.

Tagged as: 

  • Health

The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids

"We believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization," FDA officials said in a statement.

February 11, 2022
|
By:
  • Scott Hensley
Paxlovid tablets are packaged at a Pfizer factory in Italy.

Tagged as: 

  • Health

Feds' contract with Pfizer for Paxlovid has some surprises

NPR has obtained the government's $5.3 billion contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

February 02, 2022
|
By:
  • Sydney Lupkin
With its new COVID-19 vaccine, Pfizer and BioNTech are hoping to get ahead of worsening effects of omicron as well as any new variants.

Tagged as: 

  • Health

Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine

Though people who are vaccinated and boosted appear to be better protected against omicron, the highly contagious variant has still led to breakthrough cases and a surge in infections worldwide.

January 25, 2022
|
By:
  • Joe Hernandez
A resident receives a dose of the Pfizer COVID-19 vaccine at a health center in Jakarta, Indonesia, on Jan. 13. This week, Indonesia started a program to give booster shots to the elderly and people at risk of severe disease.

Tagged as: 

  • Global Health

Booster longevity: Data reveals how long a third shot protects

Researchers in the U.K. have the first estimates for how long a third shot of the Pfizer vaccine will last. The findings are mixed.

January 20, 2022
|
By:
  • Michaeleen Doucleff
Pfizer's antiviral pill Paxlovid was authorized to treat COVID-19, by the Food and Drug Administration on Wednesday.

Tagged as: 

  • Health

FDA authorizes 1st antiviral pill for COVID

In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.

December 22, 2021
|
By:
  • Scott Hensley
Fever is a possible side effect of a COVID19 vaccine.

Tagged as: 

  • Global Health

Coronavirus FAQ: What does it mean if the booster knocks me out? What if it doesn't?

Vaccine and booster side effects can include fever, aches and fatigue. And this may be the first vaccine in history where people complain if they don't experience side effects, says one doctor.

December 10, 2021
|
By:
  • Sheila Mulrooney Eldred
  • Load More

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News

Footer

Footer First Nav (Main Menu)

  • TV
  • Radio
  • News
  • Education
  • Sports
  • Events
  • Kids & Family
  • Support Us
  • Search

Footer Second Nav Menu

  • Help Center
  • About GPB
  • Contact Us
  • Closed Captioning
  • Directions
  • Studio Production
  • Program Submissions

Footer Third Nav Menu

  • Support Us
  • Careers
  • Accessibility
  • FCC Public Files
  • Drawing Rules
  • News Media Request
  • Open Records Policy
  • Privacy Policy

Georgia Public Broadcasting

260 14th St. NW
Atlanta, GA 30318
United States

(404) 685-2400 In Atlanta
(800) 222-4788 Outside Atlanta
ask@gpb.org

Newsletter Signup

Sign Up For Our Newsletters

Connect with GPB

  • Connect with GPB on Facebook
  • Connect with GPB on Instagram
  • Connect with GPB on Twitter
  • Connect with GPB on YouTube
  • Connect with GPB on Apple News
© Copyright 2023, Georgia Public Broadcasting. All Rights Reserved. Georgia Public Radio® GPTV®